| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | +15.2% | +22.9% |
| R&D Expense | $0 | — | — |
| SG&A Expense | $119K | -52.6% | -33.6% |
| Operating Income | -$191K | +44.4% | +15.1% |
| Interest Expense | $265K | +13.1% | +11.7% |
| Net Income | -$455K | +21.1% | +1.3% |
| EPS (Basic) | -$0.01 | +0.0% | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% | +0.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $183K | +4.3% | +333.6% |
| Accounts Receivable | $679K | +104.3% | +45.1% |
| Inventory | $2K | +0.0% | +0.0% |
| Current Assets | $1.1M | +66.0% | +14.4% |
| Total Assets | $1.3M | +50.0% | +8.3% |
| Current Liabilities | $15.6M | +6.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$411K | — | — |
| Capital Expenditures | $5K | — | — |
| Investing Cash Flow | -$5K | — | — |
| Financing Cash Flow | $61K | — | — |
| Free Cash Flow | -$415K | — | — |
| +11.0% |
| Long-term Debt | $1.8M | +0.0% | -0.2% |
| Total Liabilities | $17.5M | +5.3% | +9.4% |
| Stockholders' Equity | -$14.2M | -3.3% | -11.0% |